Recombinant Human T-cell surface glycoprotein CD4 (CD4), partial

What is the molecular structure of recombinant human CD4 and how does it relate to function?

Recombinant human CD4 has an elongated structure with dimensions of approximately 25 x 25 x 125 Å for a monomer when modeled as a prolate ellipsoid. Crystal structure analysis reveals that CD4 has an axial ratio of roughly 6, consistent with its extended shape. The protein typically forms a tetramer as the fundamental unit of crystallization .

The extracellular portion encompasses amino acids from Lys26 to Trp390, which contains the domains responsible for crucial interactions with binding partners . This extended, flexible structure is functionally significant as it enables CD4 to bridge the gap between T cells and antigen-presenting cells during immune synapse formation, while also providing necessary structural flexibility for interactions with MHC class II molecules and HIV gp120 .

The high solvent content observed in CD4 crystals further supports the notion of a flexible, extended structure that facilitates its diverse biological functions in cell-cell and cell-virus interactions .

How do different domains of recombinant CD4 contribute to its research applications?

Recombinant CD4 contains several functional domains that are critical for different research applications:

• MHC Class II Binding Region: CD4 binds directly to MHC class II molecules on antigen-presenting cells, contributing to the formation of the immunological synapse centered around the TCR-MHC class II-antigenic peptide interaction . This domain is essential for studies investigating T cell activation and immune synapse dynamics.

• HIV gp120 Binding Site: In humans, CD4 functions as a co-receptor for the gp120 surface glycoprotein of HIV-1 . This domain makes recombinant CD4 valuable for HIV research, including the development of entry inhibitors and vaccines.

• IL-16 Receptor Domain: CD4 acts as a chemotactic receptor for IL-16, making it relevant for research on T cell migration and inflammatory responses .

• Signaling-Associated Regions: The cytoplasmic portion contains residues that undergo palmitoylation, promoting CD4 localization in lipid rafts and enhancing TCR signaling via activation of the tyrosine kinase Lck . This domain is critical for studies on T cell signaling pathways.

Understanding these distinct domains allows researchers to design targeted experiments focusing on specific aspects of CD4 function relevant to their research questions.

What expression systems are optimal for producing functional recombinant human CD4?

The choice of expression system for recombinant human CD4 depends significantly on the intended research application:

• Mammalian Expression Systems (e.g., CHO or HEK293 cells): These are preferred when post-translational modifications, particularly glycosylation, are critical for the research application. This is especially important when studying interactions with binding partners like HIV gp120 or MHC class II molecules, which may be influenced by the glycosylation pattern.

• E. coli Expression Systems: May be suitable for producing non-glycosylated forms or specific domains of CD4 for structural studies where glycosylation is not essential. The recombinant human CD4 protein described in search result specifically includes amino acids Lys26-Trp390, suggesting a designed construct optimized for expression.

• Insect Cell Expression Systems: These offer a middle ground between proper folding/post-translational modifications and higher yield compared to mammalian systems.

For crystallization studies like those described in result , researchers often need to engineer constructs that exclude hydrophobic transmembrane regions to enhance solubility and stability. The extensive polymorphism observed in CD4 crystals highlights the challenges in obtaining homogeneous preparations suitable for structural analysis .

What methodological approaches ensure optimal purity and activity of recombinant CD4?

Based on the structural and functional characteristics of CD4, several methodological considerations are crucial:

• Construct Design: For research requiring soluble CD4, constructs should exclude the transmembrane domain while preserving key functional regions. The recombinant human CD4 described in result spans amino acids Lys26-Trp390, representing the extracellular portion.

• Purification Strategy: A multi-step purification process is typically needed:

  • Initial capture using affinity chromatography

  • Intermediate purification with ion exchange chromatography

  • Polishing step with size-exclusion chromatography to separate monomeric from oligomeric forms

• Homogeneity Assessment: The extensive polymorphism observed in CD4 crystals suggests that achieving homogeneous protein preparations is challenging but critical . Techniques like dynamic light scattering and analytical ultracentrifugation can help assess sample homogeneity.

• Activity Verification: Functional assays should verify that the purified protein retains its binding properties. For CD4, this typically involves demonstrating binding to MHC class II molecules or HIV gp120, depending on the research application .

• Stability Optimization: Given CD4's extended, flexible structure, stability can be challenging. Buffer optimization, addition of stabilizing agents, and storage at appropriate temperatures are essential considerations.

How do different methodologies for CD4 quantification compare in research settings?

Research comparing different CD4 quantification methods reveals important methodological considerations:

In a comparative study, DP flow cytometry yielded higher CD4 counts in 83% of assays compared to SP methodology. While the methods show strong correlation, 24% of samples with differences exceeding 50 cells/μL showed discrepancies greater than 100 cells .

What are the most sensitive methods for detecting functional changes in CD4 T cell subpopulations?

Recent advances in single-cell technologies have revolutionized the detection of functional changes in CD4 T cell subpopulations:

• Single-Cell RNA Sequencing: This approach has revealed previously unrecognized heterogeneity within naïve CD4 T cell populations. Unsupervised clustering analysis identified four distinct clusters within naïve CD4 T cells, each with unique marker gene expression profiles indicating different functional properties .

• High-Dimensional Flow Cytometry/Mass Cytometry (CyTOF): These techniques allow simultaneous measurement of multiple surface and intracellular markers to identify functional CD4 T cell states. The identification of naïve CD4 T cells, for example, requires a complex panel (CD3+, γδTCR-, TCR-β+, CD4+, CD25-, CD62Lhi, CD44low) .

• Functional Assays Combined with Phenotypic Analysis: Integration of functional readouts (cytokine production, proliferation) with phenotypic markers provides more comprehensive insight than either approach alone.

• Computational Analysis Approaches: Advanced bioinformatic workflows are essential for interpreting complex single-cell data. These analyses have revealed that seemingly homogeneous populations, like naïve CD4 T cells, contain functionally distinct subsets with important implications for disease outcomes .

The ability to detect subtle functional differences within CD4 subpopulations has significant research implications, as demonstrated by the finding that specific naïve CD4 T cell subclusters predict response to anti-PD-1 immunotherapy with remarkable accuracy (>90%) .

How does HIV infection impact CD4 T-cell dynamics, and what methodological approaches best capture these changes?

HIV infection has complex effects on CD4 T-cell dynamics that require sophisticated methodological approaches for accurate assessment:

• Mechanisms of CD4 Depletion:

  • HIV directly targets CD4 cells, integrating into their genome. When infected cells die, they release viral particles that infect additional CD4 cells .

  • The virus can destroy entire "families" of CD4 cells with specific antigen recognition capabilities, creating holes in the immune repertoire .

  • This cyclical process leads to progressive depletion of functional CD4 T cells, compromising immune defense against opportunistic pathogens .

• Recovery Dynamics During Treatment:

  • CD4 recovery follows a biphasic pattern during antiretroviral therapy (ART), with an initial rapid increase followed by slower long-term recovery.

  • Studies show CD4 counts continue increasing for at least 7 years on effective ART, with mean increases varying by baseline count :

    • ~390 cells/mm³ increase for patients starting below 350 cells/mm³

    • ~280 cells/mm³ increase for patients starting between 351-500 cells/mm³

    • ~180 cells/mm³ increase for patients starting above 500 cells/mm³

  • Starting ART with CD4 counts above 350 cells/mm³ provides the best chance of achieving normal immune function .

• Methodological Considerations:

  • Longitudinal monitoring is essential, as cross-sectional analyses miss important recovery dynamics .

  • Consistent methodology is crucial, as DP and SP quantification approaches can yield significantly different absolute counts .

  • Beyond quantification, functional assessments of CD4 cells provide insight into immune competence not captured by counts alone.

These findings underscore the importance of early ART initiation and highlight the value of long-term immunological monitoring in HIV research .

What research methodologies are most effective for studying CD4-HIV interactions at the molecular level?

Several complementary methodological approaches are valuable for investigating CD4-HIV interactions:

• Structural Studies:

  • X-ray crystallography has revealed critical insights about CD4's elongated structure (25 x 25 x 125 Å) and its implications for viral binding .

  • Cryo-electron microscopy provides visualization of CD4-gp120 complexes in different conformational states.

  • NMR spectroscopy can capture dynamic aspects of these interactions not apparent in static crystal structures.

• Binding Assays:

  • Surface plasmon resonance (SPR) enables real-time measurement of CD4-gp120 binding kinetics.

  • Enzyme-linked immunosorbent assays (ELISA) can quantify binding under various conditions.

  • Competitive binding assays help identify potential inhibitors of the CD4-gp120 interaction.

• Functional Cellular Assays:

  • Cell-cell fusion assays measure CD4's role in mediating HIV envelope-driven membrane fusion.

  • Pseudovirus entry assays quantify the efficiency of viral entry mediated by CD4.

  • Single-cycle infection assays assess the impact of CD4 variants or inhibitors on viral infectivity.

• Advanced Imaging Techniques:

  • Super-resolution microscopy visualizes CD4 distribution and clustering during HIV binding.

  • Single-molecule tracking captures the dynamics of CD4-HIV interactions in living cells.

  • Correlative light and electron microscopy provides both functional and ultrastructural information.

These methodologies provide complementary insights into the complex molecular interactions between CD4 and HIV, informing the development of novel therapeutic strategies targeting this critical interface .

How do specific naive CD4 T cell subpopulations impact immunotherapy response, and what methods best identify these subsets?

Recent single-cell analysis has revealed surprising heterogeneity within naive CD4 T cells with significant implications for immunotherapy response:

• Heterogeneity Within Naive CD4 T Cells:

  • Unsupervised clustering analysis identified four distinct clusters within naive CD4 T cells, each with unique marker gene expression profiles .

  • Cluster 0 (C0) represents conventional resting naive cells expressing cytoskeleton proteins.

  • Cluster 2 (C2) shows high self-reactivity, expressing markers like Nr4a1, Egr1, and Cd5.

  • Cluster 3 (C3) exhibits increased expression of interferon-induced genes .

• Impact on Immunotherapy Response:

  • The proportion of specific naive CD4 T cell subclusters (particularly C1) was significantly higher in responders to anti-PD-1 therapy compared to non-responders (p-value = 1.73e-4) .

  • A classification model incorporating naive CD4 T cell subcluster proportions improved the ability to distinguish responders from non-responders, increasing model accuracy from approximately 70% to above 90% .

• Optimal Identification Methods:

  • Single-cell RNA sequencing provides the most comprehensive characterization of these subpopulations.

  • Flow cytometry panels must include markers for both general naive T cell identification (CD3+, γδTCR-, TCR-β+, CD4+, CD25-, CD62Lhi, CD44low) and subset-specific markers identified through transcriptomic analysis .

  • Computational analysis using optimized bioinformatic workflows is essential for identifying these subtle subpopulations .

• Broader Disease Relevance:

  • Beyond cancer, these subpopulations show relevance in other immune-mediated conditions, with the C1 population significantly elevated in multiple sclerosis patients compared to healthy controls .

These findings demonstrate that seemingly homogeneous naive CD4 T cell populations contain functionally distinct subsets with important implications for predicting and understanding immunotherapy response .

What experimental designs are most effective for studying CD4 T cell differentiation and function in cancer immunotherapy?

Optimal experimental designs for studying CD4 T cell differentiation in cancer immunotherapy should integrate several methodological approaches:

• Single-Cell Analysis Platforms:

  • Single-cell RNA sequencing enables comprehensive transcriptomic profiling to identify previously unrecognized heterogeneity within CD4 T cell populations .

  • CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing) simultaneously captures surface protein expression and transcriptomes from single cells, providing multi-modal characterization.

  • These technologies have revealed distinct naive CD4 T cell subclusters with differential impacts on immunotherapy response .

• Comprehensive Cell Isolation Strategies:

  • Precise isolation of CD4 T cell subpopulations requires multi-parameter enrichment protocols.

  • Example protocol from recent research: MACS to remove CD8, CD11b, CD11c, CD19, B220, CD49b, CD105, anti-MHC class II, Ter-119, and γδTCR by negative selection, followed by flow cytometry sorting for CD3+, γδTCR-, TCR-β+, CD4+, CD25-, CD62Lhi, CD44low cells .

• Longitudinal Sampling Designs:

  • Serial sampling before, during, and after immunotherapy treatment provides critical insights into dynamic changes in CD4 subpopulations.

  • This approach can reveal how specific subsets expand or contract in responders versus non-responders.

• Integrated Multi-Omics Approaches:

  • Combining transcriptomics with epigenetic profiling, proteomics, and functional assays provides complementary insights into CD4 T cell biology.

  • Computational integration of these data types enhances the ability to identify key determinants of CD4 T cell function in the tumor microenvironment.

• Validation in Multiple Cohorts:

  • Findings should be validated across different patient cohorts to establish robustness.

  • In recent research, findings from one cancer type were validated using CITE-seq data from a different cohort, confirming the ability to distinguish responders and non-responders based on naive CD4 T cell subclusters .

These approaches collectively enable researchers to dissect the complex roles of CD4 T cell subpopulations in anti-tumor immunity and immunotherapy response .

What are the primary technical challenges in working with recombinant CD4, and how can researchers overcome them?

Researchers face several technical challenges when working with recombinant CD4 that require specific methodological approaches:

• Structural Flexibility and Stability:

  • Challenge: CD4's elongated structure (25 x 25 x 125 Å) with an axial ratio of approximately 6 contributes to its flexibility but creates challenges for structural studies and stability .

  • Solution: Crystallization studies revealed that CD4 forms a tetramer as the fundamental unit of crystallization, suggesting that engineered constructs promoting tetramerization might enhance stability .

• Polymorphism and Heterogeneity:

  • Challenge: CD4 exhibits extensive polymorphism in crystal form, with five different crystal types identified, indicating conformational variability .

  • Solution: Rigorous size-exclusion chromatography and thorough biophysical characterization (dynamic light scattering, analytical ultracentrifugation) help achieve more homogeneous preparations.

• Post-translational Modifications:

  • Challenge: Native CD4 undergoes glycosylation and palmitoylation that affect its function, particularly its localization to lipid rafts and ability to augment TCR signaling .

  • Solution: Choose expression systems appropriate to the research question—mammalian systems for studies requiring native glycosylation patterns, or enzymatic deglycosylation for applications where homogeneity is more critical than glycosylation.

• Quantification Variability:

  • Challenge: Different methods for CD4 quantification (DP vs. SP) yield different absolute values, with 42% of samples showing differences >50 cells/μL .

  • Solution: Maintain methodological consistency throughout studies and clearly report the quantification method used to enable appropriate cross-study comparisons.

• Functional Heterogeneity:

  • Challenge: Even seemingly homogeneous CD4 T cell populations contain functionally distinct subsets with different biological properties .

  • Solution: Employ single-cell analysis technologies and comprehensive marker panels to identify and characterize this heterogeneity.

Addressing these challenges requires careful experimental design and appropriate methodological choices based on the specific research question being addressed.

How can advanced computational methods enhance research on CD4 T cell biology?

Advanced computational methods have transformed CD4 T cell research, enabling deeper insights into cellular heterogeneity and function:

• Single-Cell Data Analysis:

  • Unsupervised clustering algorithms revealed four distinct clusters within naive CD4 T cells, each defined by specific marker genes that highlight unique functional characteristics .

  • Dimensionality reduction techniques (t-SNE, UMAP) enable visualization of high-dimensional data, facilitating identification of novel cell subsets.

  • Trajectory inference methods reconstruct developmental pathways of CD4 T cell differentiation from single-cell data.

• Predictive Modeling:

  • Machine learning approaches incorporating naive CD4 T cell subcluster proportions dramatically improved prediction of immunotherapy response, increasing model accuracy from approximately 70% to above 90% .

  • Projection of patients into PLS-DA (Partial Least Squares Discriminant Analysis) based latent space revealed that responders and non-responders could be clearly distinguished when naive CD4 T cell subclusters were included .

• Multi-Omics Integration:

  • Computational methods that integrate transcriptomic, epigenomic, and proteomic data provide multi-dimensional characterization of CD4 T cell states.

  • Network analysis identifies key regulatory nodes controlling CD4 T cell function.

• Structural Bioinformatics:

  • Molecular dynamics simulations model the flexibility and conformational dynamics of CD4's elongated structure (25 x 25 x 125 Å) .

  • Virtual screening and docking approaches identify potential modulators of CD4 interactions.

• Systems Immunology Approaches:

  • Agent-based modeling simulates CD4 T cell behavior in complex multicellular environments.

  • Ordinary differential equation models capture CD4 T cell population dynamics during immune responses.

These computational approaches have been instrumental in revealing previously unrecognized heterogeneity within CD4 T cell populations and identifying their functional significance in diverse disease contexts .